Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX
Perceptive Advisors LLC reported a 8.20% stake in Amylyx Pharmaceuticals, Inc. (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
Perceptive Advisors LLC reported a 8.20% stake in Amylyx Pharmaceuticals, Inc., 10,573,735 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 8.20%
- Shares
- 10,573,735
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 8.20% | 10,573,735 |
| Joseph Edelman | 8.20% | 10,573,735 |
| Perceptive Life Sciences Master Fund, Ltd. | 8.20% | 10,573,735 |
Source
Download original · View original at SEC
Related
- Amylyx Pharmaceuticals, Inc.
- Perceptive Advisors LLC
- Amylyx Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Nov 14, 2025
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2025
- Schedule 13G/A · Perceptive Advisors LLC · Feb 14, 2025
- Schedule 13G/A · Commodore Capital LP · Nov 16, 2026
- Form 4 · Frates James M · Nov 12, 2026
- Form 4 · Klee Justin B. · Nov 12, 2026
- Form 4 · Cohen Joshua B · Nov 12, 2026
- Form 4 · Milne George M Jr · Oct 7, 2026